Major Symposium E: Developing More Effective Cancer Immunotherapies

Major Symposium E: Developing More Effective Cancer Immunotherapies

Chairs:
Robert D. Schreiber, Washington Univ. Sch. of Med.
Nina Bhardwaj, Icahn Sch. of Med. at Mount Sinai

Speakers:

• James P. Allison, Univ. of Texas MD Anderson Cancer Ctr., Immune checkpoint blockade in cancer therapy: new insights and opportunities, and prospects for cures
• Robert D. Schreiber, Washington Univ. Sch. of Med., Elucidating the fundamental principles of personalized cancer vaccines
• Nina Bhardwaj, Icahn Sch. of Med. at Mt. Sinai, Targeting dendritic cells to modulate antitumor immunity
• Sandra Demaria, Weill Cornell Med., Insights into the mechanisms regulating antigenicity and adjuvanticity of irradiated tumors
• Patrick A. Ott, Dana Farber Cancer Inst., Brigham and Women’s Hosp., and Harvard Med. Sch., A personal neoantigen vaccine in patients with high risk melanoma
• Philip D. Greenberg, Univ. of Washington and Fred Hutchinson Cancer Res. Ctr., Engineering T cell responses to effectively target and then eliminate tumors